Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model
  2. Vezina, Amelie; Manglani, Monica; Morris, DreeAnna; Foster, Brandon; McCord, Matthew; Song, Hua; Zhang, Meili; Davis, Dionne; Zhang, Wei; Bills, Jessica; Nagashima, Kunio; Shankarappa, Priya; Kindrick, Jessica; Walbridge, Stuart; Peer, Cody J.; Figg, William D.; Gilbert, Mark R.; McGavern, Dorian B.; Muldoon, Leslie L.; Jackson, Sadhana
  3. Molecular Cancer Research. 2021, Dec; 19(12): 2081-2095.
  1. 2.   Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis
  2. Evrard,Yvonne; Srivastava, Anuj; Randjelovic, Jelena; Consortium, Nci PDXNet; Doroshow, James H; Dean, Dennis A; Morris, Jeffrey S; Chuang, Jeffrey H
  3. Cancer research. 2020, JUN 1; 80(11): 2286-2297.
  1. 3.   Sensitivity of mesothelioma cells to PARP inhibitors is not dependent on BAP1 but is enhanced by temozolomide in cells with high-Schlafen 11and low-MGMT expression
  2. Rathkey, Daniel; Khanal, Manakamana; Murai, Junko; Zhang, Jingli; Sengupta, Manjistha; Jiang, Qun; Morrow, Betsy; Evans,Christine; Chari,Raj; Fetsch, Patricia; Chung, Hye-Jung; Xi, Liqiang; Roth, Mark; Filie, Armando; Raffeld, Mark; Thomas, Anish; Pommier, Yves; Hassan, Raffit
  3. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020, Jan 28; pii: S1556-0864(20)30035-6.
  1. 4.   Eribulin Suppressed Cisplatinum- and Doxorubicin-resistant Recurrent Lung Metastatic Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Kiyuna, Tasuku; Tome, Yasunori; Miyake, Kentaro; Murakami, Takashi; Oshiro, Hiromichi; Igarashi, Kentaro; Kawaguchi, Kei; Hsu, John; Singh, Manish; Li, Yunfeng; Nelson, Scott; Bouvet, Michael; Singh,Shree Ram; Kanaya, Fuminori; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4775-4779.
  1. 5.   Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model
  2. Oshiro, Hiromichi; Tome, Yasunori; Kiyuna, Tasuku; Miyake, Kentaro; Kawaguchi, Kei; Higuchi, Takashi; Miyake, Masuyo; Zang, Zhiying; Razmjooei, Sahar; Barangi, Maryam; Wangsiricharoen, Sintawat; Nelson, Scott D; Li, Yunfeng; Bouvet, Michael; Singh,Shree Ram; Kanaya, Fuminori; Hoffman, Robert M
  3. Tissue & cell. 2019, Jun; 58: 17-23.
  1. 6.   A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model
  2. Kiyuna, Tasuku; Tome, Yasunori; Murakami, Takashi; Miyake, Kentaro; Igarashi, Kentaro; Kawaguchi, Kei; Oshiro, Hiromichi; Higuchi, Takashi; Miyake, Masuyo; Sugisawa, Norihiko; Zhang, Zhiying; Razmjooei, Sahar; Wangsiricharoen, Sintawat; Chmielowski, Bartosz; Nelson, Scott D; Russell, Tara A; Dry, Sarah M; Li, Yunfeng; Eckardt, Mark A; Singh, Arun S; Chawla, Sant; Kanaya, Fuminori; Eilber, Fritz C; Singh, Shree Ram; Zhao, Ming; Hoffman, Robert M
  3. Biochemical and biophysical research communications. 2018, Nov 2; 505(3): 733-739.
  1. 7.   Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model
  2. Kiyuna, Tasuku; Murakami, Takashi; Tome, Yasunori; Igarashi, Kentaro; Kawaguchi, Kei; Miyake, Kentaro; Miyake, Masuyo; Li, Yunfeng; Nelson, Scott D; Dry, Sarah M; Singh, Arun S; Russell, Tara A; Singh, Shree Ram; Kanaya, Fuminori; Eilber, Fritz C; Hoffman, Robert M
  3. Tissue & Cell. 2018, Aug; 53: 30-36.
  1. 8.   Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-p-activated nitric oxide donor PABA/NO in malignant gliomas
  2. Kogias, E.; Osterberg, N.; Baumer, B.; Psarras, N.; Koentges, C.; Papazoglou, A.; Saavedra, J. E.; Keefer, L. K.; Weyerbrock, A.
  3. International Journal of Cancer. 2012, Mar; 130(5): 1184-1194.
  1. 9.   Pharmacologic Modulation of Serine/Threonine Phosphorylation Highly Sensitizes PHEO in a MPC Cell and Mouse Model to Conventional Chemotherapy
  2. Martiniova, L.; Lu, J.; Chiang, J.; Bernardo, M.; Lonser, R.; Zhuang, Z. P.; Pacak, K.
  3. Plos One. 2011, Feb; 6(2): 8.
  1. 10.   EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
  2. Suva, M. L.; Riggi, N.; Janiszewska, M.; Radovanovic, I.; Provero, P.; Stehle, J. C.; Baumer, K.; Le Bitoux, M. A.; Marino, D.; Cironi, L.; Marquez, V. E.; Clement, V.; Stamenkovic, I.
  3. Cancer Research. 2009, Dec; 69(24): 9211-9218.
  1. 11.   In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016
  2. Russo, A. L.; Kwon, H. C.; Burgan, W. E.; Carter, D.; Beam, K.; Weizheng, X.; Zhang, J.; Slusher, B. S.; Chakravarti, A.; Tofilon, P. J.; Camphausen, K.
  3. Clinical Cancer Research. 2009 15(2): 607-612.
  1. 12.   Substitution of Aminomethyl at the Meta-Position Enhances the Inactivation of O-6-Alkylguanine-DNA Alkyltransferase by O-6-Benzylguanine
  2. Pauly, G. T.; Loktionova, N. A.; Fang, Q. M.; Vankayala, S. L.; Guida, W. C.; Pegg, A. E.
  3. Journal of Medicinal Chemistry. 2008 51(22): 7144-7153.
  1. 13.   Inactivation of O-6-Alkylguanine-DNA alkyltransferase by folate esters of O-6-Benzyl-2'-deoxyguanosine and of O-6- 4-(Hydroxymethyl)benzyl guanine
  2. Javanmard, S.; Loktionova, N. A.; Fang, Q.; Pauly, G. T.; Pegg, A. E.; Moschel, R. C.
  3. Journal of Medicinal Chemistry. 2007, Oct; 50(21): 5193-5201.
  1. 14.   Phase I trial of temozolomide plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma
  2. Quinn, J. A.; Desjardins, A.; Weingart, J.; Brem, H.; Dolan, M. E.; Delaney, S. M.; Vredenburgh, J.; Rich, J.; Friedman, A. H.; Reardon, D. A.; Sampson, J. H.; Pegg, A. E.; Moschel, R. C.; Birch, R.; McLendon, R. E.; Provenzale, J. M.; Gururangan, S.; Dancey, J. E.; Maxwell, J.; Tourt-Uhlig, S.; Herndon, J. E.; Bigner, D. D.; Friedman, H. S.
  3. Journal of Clinical Oncology. 2005, OCT 1; 23(28): 7178-7187.
  1. 15.   Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen
  2. Taverna, P.; Liu, L.; Hanson, A. J.; Monks, A.; Gerson, S. L.
  3. Cancer Chemotherapy and Pharmacology. 2000 46(6): 507-516.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel